Catherine DeVoe
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 8
- Antifungal resistance and susceptibility 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Nosocomial Infections in ICU 2
- Co-authors
- John E. Conte (2 shared papers)Jeffrey Alan Golden (2 shared papers)Emily Little (1 shared paper)Monica Fung (6 shared papers)Deborah S. Yokoe (4 shared papers)Sarah B. Doernberg (4 shared papers)Sindhu Chandran (2 shared papers)Emma D. Bainbridge (2 shared papers)
- Journals
- Nature Communications (3 papers)Open Forum Infectious Diseases (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Infection Control and Hospital Epidemiology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Catherine DeVoe
16 papers receiving 427 citations
Peers
Comparison fields: 5 of 52
- Infectious Diseases 227
- Applied Microbiology and Biotechnology 13
- Molecular Medicine 27
- Critical Care and Intensive Care Medicine 17
- Oncology 68
Countries citing papers authored by Catherine DeVoe
This map shows the geographic impact of Catherine DeVoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine DeVoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine DeVoe more than expected).
Fields of papers citing papers by Catherine DeVoe
This network shows the impact of papers produced by Catherine DeVoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine DeVoe. The network helps show where Catherine DeVoe may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine DeVoe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 73 | |
| 2 | 2013 | 61 | |
| 3 | 2020 | 56 | |
| 4 | 2020 | 44 | |
| 5 | 2021 | 41 | |
| 6 | 2010 | 39 | |
| 7 | 2010 | 37 | |
| 8 | 2022 | 26 | |
| 9 | 2024 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2024 | 12 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2018 | 2 |
About Catherine DeVoe
Catherine DeVoe is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Oncology, Clinical Biochemistry and Epidemiology, having authored 16 papers that have together received 437 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Antifungal resistance and susceptibility (3 papers), Nosocomial Infections in ICU (2 papers), Cytomegalovirus and herpesvirus research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Neutropenia and Cancer Infections (2 papers), COVID-19 and healthcare impacts (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (227 citations), Applied Microbiology and Biotechnology (13 citations), Molecular Medicine (27 citations), Critical Care and Intensive Care Medicine (17 citations) and Oncology (68 citations). Catherine DeVoe has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include John E. Conte, Jeffrey Alan Golden, Emily Little, Monica Fung, Deborah S. Yokoe, Sarah B. Doernberg, Sindhu Chandran, Emma D. Bainbridge, Timothy J. Henrich and Peter V Chin-Hong. Their work appears in journals such as Nature Communications, Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.